Laura Mainz

From Imaging to Impact: Transforming Neuro-Oncology Diagnostics - Sponsored by GE HealthCare

Imaging Meets AI: Navigating Challenges, Successes, and What's Next - Sponsored by GE HealthCare

S2 Ep37: Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

S2 Ep36: Medical Crossfire: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

S2 Ep35: Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

S2 Ep47: Breast Cancer Tumor Board®: Advancing Care in Metastatic Breast Cancer—The Evolving Role of Antibody-Drug Conjugates

S2 Ep32: Breaking Barriers in HER2-Mutant NSCLC: Exploring the Promise of Next-Generation TKIs

S2 Ep44: PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC – Expert Perspectives on New Approvals and Emerging Strategies

S2 Ep40: Tumor Board: Expert Insights on Managing Classical EGFR Mutations, EGFR Exon 20 Insertions, and Atypical EGFR Mutations in Metastatic NSCLC

S2 Ep42: Medical Crossfire®: Expert Perspectives on c-MET and MET Targeting in NSCLC—Unveiling the Complexities of MET Dysregulation